Immunogenicity of sulfatide
dc.contributor.author | Zalc, B. | en_US |
dc.contributor.author | Jacque, C. | en_US |
dc.contributor.author | Radin, Norman S. | en_US |
dc.contributor.author | Dupouey, P. | en_US |
dc.date.accessioned | 2006-04-07T17:08:07Z | |
dc.date.available | 2006-04-07T17:08:07Z | |
dc.date.issued | 1977 | en_US |
dc.identifier.citation | Zalc, B., Jacque, C., Radin, N. S., Dupouey, P. (1977)."Immunogenicity of sulfatide." Immunochemistry 14(11-12): 799-807. <http://hdl.handle.net/2027.42/22819> | en_US |
dc.identifier.uri | http://www.sciencedirect.com/science/article/B73FY-4847C20-1D/2/10441adef1d38e9f7e2d6d6261a85e0f | en_US |
dc.identifier.uri | https://hdl.handle.net/2027.42/22819 | |
dc.description.abstract | The present study deals with the immunogenicity of sulfatide. Despite its acidic character, we succeeded in raising high titer antibodies. The most effective immunization procedure involved repeated intravenous injections of a mixture of sulfatide-lecithin-cholesterol-methylated bovibe serum albumin (1:4:10:10). The respective role of the protein carrier and of the auxiliary lipids in inducing the antigencity was studied.The antibodies against sulfatide were purified by an immunoadsorption method and were characterized. They fixed complement and agglutinated. Nitrocatechol sulfate could inhibit the antibody reaction completely at high concentrations, while galactose and methyl galactoside had only a weak effect. | en_US |
dc.format.extent | 1003980 bytes | |
dc.format.extent | 3118 bytes | |
dc.format.mimetype | application/pdf | |
dc.format.mimetype | text/plain | |
dc.language.iso | en_US | |
dc.publisher | Elsevier | en_US |
dc.title | Immunogenicity of sulfatide | en_US |
dc.type | Article | en_US |
dc.rights.robots | IndexNoFollow | en_US |
dc.subject.hlbsecondlevel | Public Health | en_US |
dc.subject.hlbsecondlevel | Biological Chemistry | en_US |
dc.subject.hlbtoplevel | Science | en_US |
dc.subject.hlbtoplevel | Health Sciences | en_US |
dc.description.peerreviewed | Peer Reviewed | en_US |
dc.contributor.affiliationum | Laboratoire de Neurochimie I.N.S.E.R.M. U.134, Hôpital de la Salpêtrère 75634, Paris Cédex 13, France; Mental Health Research Institute, University of Michigan, Ann Arbor, MI 48109, U.S.A.; Laboratoire de Biochimie des Antigènes, Institut Pasteur, 75015, Paris, France | en_US |
dc.contributor.affiliationum | Laboratoire de Neurochimie I.N.S.E.R.M. U.134, Hôpital de la Salpêtrère 75634, Paris Cédex 13, France; Mental Health Research Institute, University of Michigan, Ann Arbor, MI 48109, U.S.A.; Laboratoire de Biochimie des Antigènes, Institut Pasteur, 75015, Paris, France | en_US |
dc.contributor.affiliationum | Laboratoire de Neurochimie I.N.S.E.R.M. U.134, Hôpital de la Salpêtrère 75634, Paris Cédex 13, France; Mental Health Research Institute, University of Michigan, Ann Arbor, MI 48109, U.S.A.; Laboratoire de Biochimie des Antigènes, Institut Pasteur, 75015, Paris, France | en_US |
dc.contributor.affiliationum | Laboratoire de Neurochimie I.N.S.E.R.M. U.134, Hôpital de la Salpêtrère 75634, Paris Cédex 13, France; Mental Health Research Institute, University of Michigan, Ann Arbor, MI 48109, U.S.A.; Laboratoire de Biochimie des Antigènes, Institut Pasteur, 75015, Paris, France | en_US |
dc.description.bitstreamurl | http://deepblue.lib.umich.edu/bitstream/2027.42/22819/1/0000377.pdf | en_US |
dc.identifier.doi | http://dx.doi.org/10.1016/0019-2791(77)90353-6 | en_US |
dc.identifier.source | Immunochemistry | en_US |
dc.owningcollname | Interdisciplinary and Peer-Reviewed |
Files in this item
Remediation of Harmful Language
The University of Michigan Library aims to describe library materials in a way that respects the people and communities who create, use, and are represented in our collections. Report harmful or offensive language in catalog records, finding aids, or elsewhere in our collections anonymously through our metadata feedback form. More information at Remediation of Harmful Language.
Accessibility
If you are unable to use this file in its current format, please select the Contact Us link and we can modify it to make it more accessible to you.